Krajina: Austrália
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
drospirenone, Quantity: 3 mg; ethinylestradiol, Quantity: 30 microgram
Medis Pharma Pty Ltd
Drospirenone,ethinylestradiol
Tablet, uncoated
Excipient Ingredients: lactose monohydrate; dl-alpha-tocopherol; maize starch; pregelatinised maize starch; brilliant blue FCF; magnesium stearate
Oral
1 x 28 (21 active tablets and 7 inert tablets), 2 x 28 (each contains 21 active tablets and 7 inert tablets), 3 x 28 (each contains 21 active tablets and 7 inert tablets), 4 x 28 (each contains 21 active tablets and 7 inert tablets)
(S4) Prescription Only Medicine
indicated for use as an oral contraceptive
Visual Identification: blue, round, flat-faced, beveled edge uncoated tablets, debossed 'WATSON' on one side and '981' on the other side.; Container Type: Blister Pack; Container Material: PCTFE (Aclar)/AI; Container Life Time: 15 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2013-01-11